Liver Cancer
- Colon, Esophagus, Liver, Lung, Other Digestive Organ, Phase I, StomachA Phase 1/2, Multicenter, Open-Label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of YL242 Monotherapy and Combinations in Advanced Solid Tumors
- Colon, Liver, Lung, Other Skin, Other Urinary, Phase I, Rectum, Urinary BladderA Phase I/II, Open-label, Multicenter Study of ALE.P03 (Claudin-1 Targeted Antibody-drug Conjugate) as a Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- Colon, Esophagus, Liver, PancreasA Phase 2 Nonrandomized, Open-label, Multisite Study to Evaluate the Safety and Efficacy of Raludotatug Deruxtecan in Participants With Gastrointestinal CancersPrincipal Investigator: Raghav Sundar
- Anus, Bones and Joints, Breast, Colon, Esophagus, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, ThyroidPROgram to address psychosocial Support, clinical outcomes, and genomic insights for Patients with EaRly onset cancers